Malaysia Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
December 24, 2014
139 Pages - SKU: BMI5432436
Countries covered: Malaysia

Malaysia Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Malaysia's 2015 budget reinforces our upbeat outlook on the country's pharmaceutical market.Rising healthcare expenditure plans to improve medical access and efforts to mitigate the impact of theGoods and Service Tax on medicine prices will provide companies with significant revenue-earningopportunities. However, downside risks to our outlook include further economic slowdown forecast for2015, worries of an increasing number of imitation drugs and growing political differences within both theopposition and ruling coalitions.

Headline Expenditure Projections

Pharmaceuticals: MYR6.60bn (USD2.10bn) in 2013 to MYR7.22bn (USD2.25bn) in 2014; +9.3 % inlocal currency and +7.6% in US dollar terms. Forecast revised down from last quarter to better suitcurrent market conditions.



More Prescription Drugs reports by Business Monitor International

Tanzania Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Tanzania Pharmaceuticals and Healthcare Report Q2 2015BMI View: Tanzania's pharmaceutical market will continue to see growth with the continuing expansion ofthe country's National Health Insurance ...
Singapore Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Singapore Pharmaceuticals and Healthcare Report Q2 2015BMI View: Singapore will remain a highly attractive manufacturing base for international pharmaceuticalcompanies due to minimal levels of operational ...
Poland Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Poland Pharmaceuticals and Healthcare Report Q2 2015BMI View: The Polish pharmaceutical market is heavily dependent on public healthcare spending; anynegative economic developments will have an ...
Peru Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Peru Pharmaceuticals and Healthcare Report Q2 2015BMI View: Longstanding trade agreements with the US and EU, along with efficient regulations for qualitycontrol will continue to ...
See all reports like this >>

More Malaysia Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Malaysia Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Malaysia Q4 2014BMI View: The Malaysian pharmaceutical and healthcare markets are set to grow significantly. Promisinglong-term economic growth, local government ...
Antibiotics Market in Malaysia to 2016 by Global Research & Data Services Oy
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Malaysia. The study provides essential market ...
The Pharmaceutical Market: Malaysia by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Malaysia (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!